The proteasome inhibitor MG132 enhances LDL uptake in hepatocytes through regulating LDLR and PCSK9 expression: a novel role in cholesterol homeostasis

CORC > 上海药物研究所 > 中国科学院上海药物研究所 > 药理学第一研究室

	The proteasome inhibitor MG132 enhances LDL uptake in hepatocytes through regulating LDLR and PCSK9 expression: a novel role in cholesterol homeostasis
	Yan, Hong 1,2; Ma, Yan-ling 1,2; Wang, Xin-bo 1,2; Gui, Yu-zhou 1,2; Gao, Fei 1,2; Wang, Yi-ping1
	2013-07
关键词	Low-density lipoprotein receptor proprotein convertase subtilisin/kexin type 9 protein kinase C hamster
卷号	34
页码	95-95
会议录	ACTA PHARMACOLOGICA SINICA
会议录出版者	ACTA PHARMACOLOGICA SINICA
文献子类	Meeting Abstract
语种	英语
WOS研究方向	Chemistry ; Pharmacology & Pharmacy
WOS记录号	WOS:000322051500419
内容类型	会议论文
源URL	[http://119.78.100.183/handle/2S10ELR8/266174]
专题	药理学第一研究室中科院受体结构与功能重点实验室新药研究国家重点实验室
作者单位	1.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; 2.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
推荐引用方式 GB/T 7714	Yan, Hong,Ma, Yan-ling,Wang, Xin-bo,et al. The proteasome inhibitor MG132 enhances LDL uptake in hepatocytes through regulating LDLR and PCSK9 expression: a novel role in cholesterol homeostasis[C]. 见:.